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Effects of Inducible cAMP Early Repressor (ICER) on Herpes Simplex Virus -1 (HSV-1)
Infectivity

Abstract
While inducible cAMP early repressor (ICER) is known for many roles, including inhibition of
anti-apoptosis transcription and regulation of hormone signaling in human / animals, little is
known of the role of ICER when interacting with viral cAMP responsive elements (CREs). Prior to
this study, CRE sites were found in a variety of human viruses, in locations relating to DNA
binding, DNA replication, and latency. A gel shift assay confirmed that ICER can bind to viral CRE
sequences, and a reporter gene assay demonstrated that the presence of ICER on a viral
promoter upregulates viral expression.
In an attempt to further understand the effects of ICER on viral replication, an in vivo study
was conducted, focused on infecting an inducible expression system and analyzing the changes
of viral infectivity, using Herpes Simplex Virus-1 as a model virus. In addition, two variants of
ICER (an HA tag on the carboxyl terminus and an HA tag on the amino terminus) were studied.
This study demonstrates that inducing ICER with an HA tag on the C-terminus limits the viral
replication capacity in Vero cell cultures.
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Chapter 1: Introduction
1.1 cAMP Responsive Elements (CREs)
1.1.1 CREs Sequence and Locations
A cAMP Responsive Element (CRE) is a short DNA sequence, which bind transcriptional
activators and repressors induced by increased levels of cAMP. CREs are palindromes, with a
consensus sequence of (5’-TGACGTCA-3’) or half-palindrome (5'-TGACG-3' and 5'-CGTCA-3'). In
a bioinformatic search of conserved CRE sites in humans and mice, more than half of the time,
the CRE was located about 200 nucleotides away from the transcription start site. A total of
3,025 genes were identified; 38% genes related to transcription factors, 24% are related to
metabolism, and 33% are related to genes involving cell cycle (Zhang et al, 2005). While CRE
locations and target genes vary, there are three major protein families which bind to CREs:
CREM, CREB, and ATF-1.

1.2 Inducible cAMP early repressor (ICER)
1.2.1 ICER Structure, Induction and Function
cAMP responsive element modulator (CREM), cAMP responsive element binding protein
(CREB), and activating factor-1 (ATF-1) are proteins that bind to cAMP responsive element
(CRE). Of the three protein families, only CREM produces transcriptional activators and
repressors. (Molina, 1993). The CREM gene contains four promoters, where promoter 2 (P2)
contains two DNA binding domains. Upon increased levels of cAMP, there is an increase in the
transcription and translation of CREM, and through alternative splicing, an intron of the CREM
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gene then becomes inducible cAMP early repressor (ICER), a protein that only contains a DNA
binding domain, and lacks a transactivation or kinase inducible domain (Molina, 1993; Laiode,
1993).

Figure 1: CREM Promoter. Figure 1a represents the intron / exons located in the promoters of cAMP Responsive Element
Modulator (CREM). Figure 1b represents the different ICER isoforms. Source: Borlikova, Gilyana, and Shogo Endo. "Inducible
cAMP early repressor (ICER) and brain functions." Molecular neurobiology 40.1 (2009): 73-86.

There are four isoforms of ICER: ICER I, ICERI γ, ICER II, and ICER II γ. ICER I γ and ICER II γ
contain the gamma exon. ICER I contains DNA Binding Domain I, and ICER II contains DNA
Binding Domain II (Foulkes, Borrelli, Sassone-Corsi, 1991). Due to the lack of a transactivation
domain, ICER is unable to execute transcription, and only bind to CRE sequences. It can
dimerize with phosphorylated CREB (pCREB) or homodimerize with itself and repress
expression of pCREB / CREM through competitive binding. Therefore, after high levels of cAMP,
ICER negative regulates cAMP induced gene expression (Molina, 1993).
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1.2.2

ICER regulation

ICER itself is regulated on a transcriptional level. The CREM / ICER promoter (P2) contains
four repeating CREs, called cAMP regulatory elements (CARE). Proteins that are able to bind to
CRE also bind to CARE sequences (Molina, 1993). Therefore, after ICER competitively represses
pCREB, CREM, or ATF-1, these proteins can bind to the CARE sequence in the promoter and
inhibit ICER expression.

1.2.3 ICER Degradation
Cellular concentrations of ICER are maintained through degradation, rather than posttranslational modifications. In an experiment performed by Folco and Koren in 1997, inhibition
of the proteasome caused increased levels of ICER-ubiquitin, demonstrating that ICER is
removed from the cell through ubiquitination and the proteasome (Folco, 1997).

1.2.4 ICER And Stress Signaling
ICER plays part in many critical roles in signal transduction, and its transcription is
dependent on the quality and quantity of signal introduced into the cell / tissue. Stress, for
example, can induce ICER expression. In a study where rats were exposed to surgical stress, an
increase in ICER was found in the adrenal glands. When the pituitary gland was removed, a
decrease in the production of ICER occurred. This is significant because the pituitary gland
secretes adrenocorticotropin hormone (ATCH), which in turn increases levels of cAMP in the
adrenal glands and leads to further production of steroids in response to stress. When the rats
with removed pituitary glands are injected with ATCH, transient induction of ICER was observed
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(Della Fazia, 1998). This established that ICER is involved in the regulatory cascade that
activates the production of steroids in the adrenal gland.
It was hypothesized by researchers that ICER had an anti-apoptotic effect, as removal of the
pituitary causes atrophy in the adrenal cortex, and an overproduction of ATCH causes
hypertrophy. In addition, because this experiment already proves that CREM/ ICER is produced
with the presence of ATCH in the adrenal gland, ICER perhaps can repress cyclin A and allow the
cell to move forward the G2/M phase (Della Fazia, 1998).

1.2.5 ICER and Apoptosis
This hypothesis, however, contrasts in vitro findings of ICER and apoptosis. In neuronal cell
cultures undergoing cell death, an upregulation of ICER was found. Bcl-2, an anti-apoptotic
protein, is also a pCREB target. An overexpression of ICER in vitro therefore causes cell death by
competitively binding to pCREB target of the Bcl-2 promoter; silencing anti-apoptotic
expression (Konopka, et al, 1998). It is to note that when tested in vivo, overexpressing ICER in
neuronal cells does not cause cell death; as it is probable that neuronal cell death is more
tightly regulated by many signaling systems (Mouravlev et al, 2006).

1.3 CRE sequence in Viral Genomes
1.3.1 Bioinformatic Search
In an attempt to understand the pandemic the world experienced beginning in 2019, the
sequence of SARS-CoV-2 virus (NCBI Reference Sequence: NC_045512.2) was previously
analyzed by Michelle Oh in 2020. The canonical CRE site was not found to align, but variants of
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the CRE sequence (5’-TGACATCA-3’, 5’-TGATGTCA-3’, 5’-TGACATAA-3’, 5’-TGAGGTCA-3’, and 5’TCGATCAA-3’) were found in multiple locations within the viral DNA sequence.
The search for CRE sites was then expanded to all human viruses. Many viruses were
found to contain either canonical or variants of the CRE sequences. Those with canonical CREs
include Human Parvovirus, Yellow Fever virus, Influenza A virus, Human adenovirus, Rotavirus,
and Human herpesvirus. Those with variant CRE sequences include Human Papillomavirus,
Ebolavirus, Zika virus, and Hepatitis C virus. When the location of the CRE sequences within
these viruses were related to viral function, many were linked to either DNA binding, DNA
replication, or latency. In order to study the in vivo effects of ICER on viral CREs, Herpes Simplex
Virus-1 (HSV-1) was chosen as a model virus, as an attenuated safe strain for laboratory studies
was available. The HSV-1 also contained green fluorescent protein (GFP), allowing for visible
infectivity to cell culture.

1.4 Herpes Simplex Virus -1 (HSV-1)
1.4.1 HSV-1 Classification and Structure
Herpes Simplex Virus -1 (HSV-1) is a large enveloped alpha herpesvirus, containing
double stranded DNA. There are two types of Herpes simplex virus, type I and type II. Herpes
Simplex Virus type II is known as the causative agent of genital warts, and Herpes Simplex Virus
type I is known as the causative agent of cold sores. The herpes virus contains 74 open reading
frames, encoding 84 different proteins, all of which are transcribed by the host’s RNA
polymerase II. The Herpes viral genome contains two major sections, the long unique region
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and the short unique region. The long unique region contains 56 of the 72 open reading frames
(Boehmer et al, 2003).

1.4.2 HSV-1 Replication
HSV-1 enters host cells by binding to transmembrane receptors of the epithelial cells
and fusing its viral envelope to the cell membrane, creating a pore in which the contents of the
virus can enters the cell. The virion travels through the cytoplasm and upon encountering the
nuclear envelope, the viral capsid binds to the nuclear envelope and injects the DNA into the
nucleus. During lytic infection, HSV creates early response proteins that interrupt host protein
synthesis and degrade host mRNA, in order to produce more viral double stranded DNA
(Copeland et al, 2009).
Only upon latent infection does the virus travel to the terminal of sensory neurons and
terminate transcription of all viral proteins, except for latency associated transcript (LAT). This
transcript interferes with the host cell's apoptotic responses and allows viruses to survive
silently in host cells until it is time to infect other cells. Stress signals or cell death usually cause
HSV-1 to change from a latent infection to an active, lytic one (Bloom et al, 2010).

1.5 Experimental Design
To begin, Vero cells were utilized to generate an inducible system that would express ICER
when exposed to doxycycline. Vero cells originate from the African Green Monkey epithelial
kidney cells, a model cell line ideal for studying viral infection(Ammerman et al, 2008).
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Two variants of ICER were tested. An antibody tag (HA) was placed on both the carboxyl
(C)- terminus and amino (N)- terminus of the ICER protein. A pending paper by Dr. Carlos
Molina suggests that blocking the N- terminus causes immediate ubiquitination and ultimate
degradation of the protein, which in turn disrupts essential cell function and causes apoptosis.
Therefore, efficiency of ICER was tested by utilizing the two variants. ICER was integrated to the
Vero cell line using the pTETone system, which will randomly integrate ICER into the genome.
As a control, luciferase was transfected in place of ICER to test the effectiveness of the Tet on
system, as the protein will luminesce when the system is on.
Upon successful growth of luciferase, pTetOne-ICER-(HA-N) and pTetOne-ICER (HA-C) were
tested with PCR as well as western blotting to ensure ICER had integrated into the genome and
was inducible. The Vero cells were infected with Herpes simplex virus-1, that contained GFP in
its genome (De Oliveira, et al, 2013). Fluorescent microscopy was then used to analyze the
change of infectivity of HSV-1 in the presence and absence of ICER. The data gathered will then
provide insight into the possible effect ICER has on HSV-1 capacity to replicate in mammalian
cell culture.

Figure 2: pTetOne ICER Plasmids. The figures demonstrates integration of ICER into the pTetOne plasmid. On the left is ICER (NHA) integration into pTetOne, and on the right is ICER (C-HA) integration into pTetOne.
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Chapter 2: Materials and Methods
2.1

Cloning ICER into Tet-One Inducible System
Cloning of ICER followed the Clontech® Laboratories, Inc. Tet-One Inducible Expression

System User Manual (Takara Bio, USA), using In-Fusion HD. pTet-One plasmid were linearized
with EcoRI and BamHI, and primers for integration of ICER into the pTet-One plasmid are as
follows:

Forward
Primer
5’ – 3’
Reverse
Primer
5’ – 3’

ICER (N-HA)

ICER (C-HA)

CCCTCGTAAAGAATTC
CGCGTCATATGGCTAGCGT

GCAGAGATCTGGATC
CGAATTCTCAGGCGTAGTCGGG

GCAGAGATCTGGATCC
TGCAGAATTCTCATTCGTTCTTGCAG

CCCTCGTAAAGAATTC
TCATATGGCTAGCGTTTAAACTTAAGCTTGG

Table 1: PCR Primers for ICER integration into pTetOne. Forward and reverse primers were generated to join linearized pTetOne
plasmid with ICER. Primers created for both ICER (C-HA) and ICER (N-HA).

2.2

Vero Cell Culture
Vero cells were cultured in doxycycline free Eagle’s minimum essential medium (EMEM)

and cultivated at 37°C with 5% CO2.

2.3

ICER Transfection
Cell cultures was transfected with ICER following the XfectTM Transfection Reagent

Protocol-At-A-Glance (Takara Bio, USA), using 1 ng – 100 ng of template DNA, 100 ng of the
hygromycin selection marker, and transfected in 10% FBS – tetracycline free. Plasmids were
selected for with 150 ug/mL of hygromycin. After 48 hours; peak transfection was read, and
adherent colonies were selected.
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2.3

Assay for ICER Integration in Vero Cells: PCR
Applied Biosystems AmpFLSTR™ Identifiler™ PCR Amplification Kit (Thermo Fisher

Scientific, USA) , rapid DNA extraction protocol was used to amplify the region of ICER selected
using PCR. The selected primers amplified the promoter and ICER; ensuring that ICER was
integrated in the correct orientation. Correct integration of ICER would yield a 576 bp PCR
product.

Forward Primer
5’ – 3’
Reverse Primer
5’ – 3’

ICER (N-HA)
ACCTCTACAAATGTGGTATGGCT
GA
TAAAAGAGTGCTGATTTTTTGAG
TAAACTTCAATTCC

ICER (C-HA)
TGTGGGAGGTTTTTTAAAGCAAGTAAA
ACC
TTTGAGTAAACTTCAATTCCACAACACTT
TTGT

Table 2: PCR Primers of ICER Integration into pTETOne. Forward and Reverse primers were created to amplify a 576 bp region,
encompassing the TRE3GS promoter and the ICER gene.

2.4

Assay for ICER Inducibility: Western Blot
Colonies were tested with Western Blot to ensure ICER was inducible in the presence of

100 ng of doxycycline. Culture medium was removed, and cells were washed before fixed with
4% formaldehyde. Cells were washed again, and reheated Antigen Revival Buffer was added
before rewashing with PBS. All remaining PBS was removed, and wells were placed on a plate
shaker with Protein Block before the primary antibody added. After washing, the plates were
imaged.

2.5

Viral Infection
Cell cultures grown in 6 well (9.6 cm2) cell culture plate were infected with 100 µL of

HSV-1, and shaken every 15 minutes for an hour, and incubated for 72 hours at 37°C with 5%
CO2.
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Chapter 3: Results
3.1

Transfection of ICER into Vero Cell Line
Use of negative selection marker hygromycin yielded 7 clones of ICER (N-HA) and 9

clones of ICER (C-HA). Clones were then harvested, and PCR primers were designed for
amplification of the ICER sequence. Expected PCR size was 576 bp, as the PCR primers tested
the orientation and location of ICER’s insertion into the cell line. The PCR products showed only
4 potential clones thought to have the gene: two clones of ICER (C-HA) and ICER (N-HA). While
one clone from each variant of ICER tested had expected PCR amplicon of ~576 bp (VN5 and
VC4), the other clones had bands near ~1000 bp (VN4 and VC9) (Fig. 3). While this may have
occurred due to double integration of ICER in the same site, it did not discount the possibility of
a functional gene product.

Figure 1:
S Amplification
Q
\* of ICERCinto pTETOne
f plasmids.
f CThe figure on the
O left shows PCR primers of ICER (C-HA)
C and ICER (N-HA)
f
clones. Nomenclature: Vero cells = V, ICER (C-HA) = C, and ICER (N-HA) = N. Number denotes the clone number. VN4 and VC9
have DNA bands ~1000 bp, indicative of double integration. VC4, VC9, and VN5 have clear DNA bands near expected ICER bands
(~576 bp). Negative control was PCR water, and positive control was the ICER plasmid. The figure on the right is a
representation of a gel, in which the same PCR primers for amplification of ICER in the pTetOne system, has ICER double
integrated in the same site (lane 2). Lane 1 is the supercoiled pTetOne-ICER plasmid.
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Western blotting was used to then test the inducibility of ICER expression, when
cultured with doxycycline. The expected molecular weight of ICER was 15-20 kd. Three clones
were tested for inducibility, VN4, VC4, and VC5 (Fig. 4). Clone VN5 demonstrated definitive
inducibility in the presence of doxycycline.

100 kd

S Q
\*
C
f
f
Figure 2: Western Blot of Vero-ICER clones. An anti-HA tag was used for western blotting of ICER (C-HA) and ICER (N-HA).
Absence of doxycycline is represented with a (-) and presence of doxycycline is represented with a (+). Inducibility of ICER
is demonstrated by a double band, present between 15-20 kd. VN5+ showed clear inducibility of ICER under doxycycline.
The negative control was Vero cells without ICER present, and the positive control was Vero cells transiently infected with
the ICER plasmid. Nonspecific binding occurred 100 kd.

3.2

Vero Cell Line Infection with HSV-1
ICER (C-HA), ICER (N-HA) and ICER (Luciferase) were infected with HSV-1, and

fluorescence was visually assessed after 24 hours and 72 hours. At 24 hours post- infection,
clones grown in the presence of doxycycline, including the luciferase control, lacked presence
of viral GFP. This indicates a possible delay in viral replication in the presence of doxycyline.
After 72 hours, as demonstrated in the expression of viral GFP in the presence of doxycyline,
clones containing the luciferase control and theICER (N-HA) variant demonstrated viral
infectivity ..The ICER (C-HA) variant lacked production of viral GFP after 72 hours. At both 24
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and 72 hours of infectivity, all clones (luciferase, ICER (C-HA), and ICER (N-HA) grown in the
absence of doxycyline showed presence of viral GFP. (Fig. 5).

Figure 3: Fluorescent Microscopy of viral infection. Luciferase clone VL8, ICER (N-HA) clone VN5, and ICER (C-HA) clone VC4
were infected with HSV-1 and incubated for 24 hours and 72 hours.
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Chapter 4: Discussion
Induction of ICER was not clearly observed for western blotting of ICER (C-HA) clone VC4
(Fig. 4). The amount of doxycycline used in the media is a factor, as 100 ng may not have been
sufficient to cause induction.
Infectivity of Herpes simplex virus -1 (HSV-1) was not observed in the presence of ICER
(C-HA) after 72 hours. Concentration of doxycycline used did not cause cell death, as cell
growth and viral infectivity was observed in the luciferase and ICER (N-HA) cell cultures (Fig. 5).
There was no difference in the process of viral infection performed between the
luciferase control, ICER (N-HA), and ICER (C-HA) cell cultures, and therefore rules out procedure
/ process of infection as cause of the repression of infectivity in the ICER (C-HA) cell line. While
it is possible there was not enough ICER present during western blotting to be induced in 100
ng of doxycycline, it is possible that when cultured for 72 hours, there may have been enough
induction of ICER to limit viral infectivity. If ICER were not present in the VC4 clone in the
presence of doxycycline, results would appear as they do for the VC4 clone without
doxycycline, where ICER is not expressed.
Follow up studies that may be performed to confirm ICER (C-HA) inhibits viral infectivity
is performing western blotting / infection with higher concentrations of doxycycline, to ensure
ICER is expressed in sufficient quantities in the cell line.
Other factors to challenge the results are the cell line chosen and the mechanism of
ICER integration into the cell line. The Vero cell line was used as it is a model cell line to study
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viral infection. However, a human cell line may yield different results, as it aligns closer to in
vitro effects of HSV-1 in the presence of ICER. Transfection of the pTetOne into the cell line
caused random integration of the plasmid into the genome. A different technique to use would
be a site-specific integration of the plasmid into the cell line, ensuring ICER is not integrated in a
part of the genome related to cell function / cell proliferation.
However, if further studies still determine that ICER (C-HA) can limit viral infectivity, this
evidence supports the hypothesis that inhibiting the amino terminus of ICER causes a nonfunction protein product. In addition, further studies can be done to study the mechanism of
action between HSV-1 and ICER. While results generated during this study contrasts results
previously generated during a reporter gene assay of a viral promoter and ICER, perhaps the
infection stage of HSV-1 reacts differently in the presence of ICER. HSV-1 CRE sequences are
found on LAT genes, which are expressed during lytic and latent infection, and are found to
repress expression of viral proteins during latency. While HSV-1 is in latency, ICER has been
found to upregulate the expression of viral proteins, and reestablish a lytic phase (Colgin et al,
2001). There is little research about the lytic phase of HSV-1 and effects in the presence of ICER.
If indeed ICER can repress lytic viral infection, then this may be used as a source of treatment
for these infections.

Page 22

Chapter 5: Conclusion
Infecting cell cultures that express an ICER with a blocked carboxyl terminus is shown to
repress HSV-1 replication abilities. Further experiments should be performed to challenge the
results generated, and if results prove to be consistent, two avenues of investigation can be
investigated. The first would be understanding the difference in viral infectivity capabilities
between ICER (C-HA) and ICER (N-HA). The second avenue of research would be determining
why and how ICER is able to repress lytic viral replication. Data generated from these avenues
of research will allow deeper insight for the use of ICER as a potential biologic anti-viral
treatment for not only HSV-1, but any viruses that contain CRE sites.
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